Författarna: |
Malmström, Erik, Malmström, Lars, Hauri, Simon, Mohanty, Tirthankar, Scott, Aaron, Karlsson, Christofer, Gueto-Tettay, Carlos, Åhrman, Emma, Nozohoor, Shahab, Tingstedt, Bobby, Regner, Sara, Elfving, Peter, Bjermer, Leif, Forsvall, Andreas, Doyle, Alexander, Magnusson, Mattias, Hedenfalk, Ingrid, Kannisto, Päivi, Brandt, Christian, Nilsson, Emma, Dahlin, Lars B, Malm, Johan, Linder, Adam, Niméus, Emma, Malmström, Johan |
Övriga upphovsmän: |
Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section III, Infection Medicine (BMC), Translational Sepsis research, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion III, Infektionsmedicin, Translationell Sepsisforskning, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section III, Infection Medicine (BMC), epIgG, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion III, Infektionsmedicin, epIgG, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section III, Infection Medicine (BMC), Infection Medicine Proteomics, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion III, Infektionsmedicin, Infection Medicine Proteomics, Originator, Lund University, Faculty of Medicine, Department of Experimental Medical Science, Lung Biology, Lunds universitet, Medicinska fakulteten, Institutionen för experimentell medicinsk vetenskap, Lungbiologi, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section II, Thoracic Surgery, Neurological injury in acute type A aortic dissection, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion II, Thoraxkirurgi, Neurologiska skador vid akut aortadissektion typ A, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section II, Thoracic Surgery, Minimal invasive cardiac surgery in valvular heart disease, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion II, Thoraxkirurgi, Minimalinvasiv hjärtkirurgi vid hjärtklaffsjukdom, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section II, Thoracic Surgery, Bleeding disorders and acute typ-A dissection, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion II, Thoraxkirurgi, Blödningsrubbningar och akut typ-A dissektion, Originator, Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section V, Surgery (Lund), Hepato-Pancreato-Biliary Surgery, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion V, Kirurgi, Lund, Lever-, pankreas- och gallvägskirurgi, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Malmö, Surgery, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Malmö, Kirurgi, Originator, Lund University, Faculty of Medicine, Department of Translational Medicine, Urological cancer, Malmö, Lunds universitet, Medicinska fakulteten, Institutionen för translationell medicin, Urologisk cancerforskning, Malmö, Originator, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Molecular Medicine and Gene Therapy, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för molekylärmedicin och genterapi, Originator, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Molecular Medicine and Gene Therapy, Stem cell and Cancer stem cell Regulation, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för molekylärmedicin och genterapi, Stamceller och cancerstamcellsreglering, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), StemTherapy: National Initiative on Stem Cells for Regenerative Therapy, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), StemTherapy: National Initiative on Stem Cells for Regenerative Therapy, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Breast/ovarian cancer, Breast and Ovarian Cancer Genomics, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Bröst/ovarialcancer, Bröst- och ovarialcancer, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), EpiHealth: Epidemiology for Health, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), EpiHealth: Epidemiology for Health, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section V, Obstetrics and Gynaecology (Lund), Advanced ovarian cancer, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion V, Obstetrik och gynekologi, Lund, Avancerad ovarialcancer, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section IV, Neurosurgery, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion IV, Neurokirurgi, Originator, Lund University, Faculty of Medicine, WCMM-Wallenberg Centre for Molecular Medicine, Lunds universitet, Medicinska fakulteten, WCMM- Wallenberg center för molekylär medicinsk forskning, Originator, Lund University, Faculty of Medicine, Department of Translational Medicine, Hand Surgery, Malmö, Lunds universitet, Medicinska fakulteten, Institutionen för translationell medicin, Handkirurgi, Malmö, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section V, Mass Spectrometry, Clinical Protein Science and Imaging, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion V, Masspektrometri, Clinical Protein Science and Imaging, Originator, Lund University, Faculty of Medicine, Department of Translational Medicine, Clinical Chemistry, Malmö, Lunds universitet, Medicinska fakulteten, Institutionen för translationell medicin, Klinisk kemi, Malmö, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section II, Thoracic Surgery, Heparin bindning protein in cardiothoracic surgery, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion II, Thoraxkirurgi, Heparinbindande protein inom thoraxkirurgi, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section III, Infection Medicine (BMC), SEBRA Sepsis and Bacterial Resistance Alliance, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion III, Infektionsmedicin, SEBRA Sepsis and Bacterial Resistance Alliance, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Biomarkers and epidemiology, Breast cancer Proteogenomics, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Biomarkörer och Epi, Bröstcancer Proteogenomik, Originator, Lund University, Faculty of Engineering, LTH, LTH Profile areas, LTH Profile Area: Engineering Health, Lunds universitet, Lunds Tekniska Högskola, LTH profilområden, LTH profilområde: Teknik för hälsa, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section V, Mass Spectrometry, BioMS, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion V, Masspektrometri, BioMS, Originator |
|